|
Volumn 69, Issue 6 Suppl, 2003, Pages 32-38
|
Atypical antibody responses in dengue vaccine recipients.
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
LIVE VACCINE;
VIRUS ANTIBODY;
VIRUS VACCINE;
ADOLESCENT;
ADULT;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DENGUE;
DENGUE VIRUS;
FEMALE;
HEMAGGLUTINATION INHIBITION TEST;
HUMAN;
IMMUNOLOGY;
MALE;
MIDDLE AGED;
PHASE 1 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
SERODIAGNOSIS;
VACCINATION;
VIREMIA;
ADOLESCENT;
ADULT;
ANTIBODIES, VIRAL;
CLINICAL TRIALS, PHASE I;
DENGUE;
DENGUE VIRUS;
FEMALE;
HEMAGGLUTINATION INHIBITION TESTS;
HUMANS;
MALE;
MIDDLE AGED;
NEUTRALIZATION TESTS;
RANDOMIZED CONTROLLED TRIALS;
VACCINATION;
VACCINES, ATTENUATED;
VIRAL VACCINES;
VIREMIA;
|
EID: 1342310102
PISSN: 00029637
EISSN: None
Source Type: Journal
DOI: 10.4269/ajtmh.2003.69.32 Document Type: Article |
Times cited : (23)
|
References (0)
|